Hostname: page-component-5c6d5d7d68-xq9c7 Total loading time: 0 Render date: 2024-08-21T20:50:32.871Z Has data issue: false hasContentIssue false
  • English
  • Français

Pfizer, Inc. v. Government of India. 98 S. Ct. 584

Published online by Cambridge University Press:  27 February 2017

Alona E. Evans
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Judicial Decisions
Information
American Journal of International Law , Volume 72 , Issue 3 , July 1978 , pp. 662 - 663
Copyright
Copyright © American Society of International Law 1978

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

* Full text in 17 ILM 93 (1978).

1 The Republic of Vietnam was also party to this suit; however, the complaint was dismissed on the ground that an unrecognized government could not maintain an action in a United States court. On appeal, this decision was affirmed. Republic of Vietnam v. Pfizer, Inc., 556 F.2d 892 (8th Cir. 1977); 72 AJIL 152 (1978).

2 Section 4 provides: Any person who shall be injured in his business or property by reason of anything forbidden in the antitrust laws may sue therefore in any district court of the United States in the district in which the defendant resides or is found or has an agent, without respect to the amount in controversy, and shall recover threefold the damages by him sustained, and the cost of suit, including a reasonable attorney's fee.

3 98 S. Ct. 590.

4 Id., 591.

5 Id., 592.

6 Id.